This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Regorafenib Assessment in Refractory Advanced Colo...
Clinical trial

Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)

Read time: 1 mins
Last updated:28th Jul 2013
The general objectives are to evaluate activity and the safety of regorafenib in a population of patients bearing advanced, refractory colorectal cancers and to explore the different downstream molecular pathways to identify tumor response and resistance mechanisms.
Category Value
Study start date 2013-07-28

View full details